Genialis Collaborates with Oncologie on Precision Medicine Initiative in Gastric Cancer
Shots:
- The collaboration will combine Genialis’ expressions software platform and analytics IP with Oncologie’s clinical and translational expertise to refine patient stratification methodologies
- The companies will initially focus on modeling gene expression signatures predictive of treatment for gastric cancer. The methodology will further enhance Oncologie’s clinical development plans to expand beyond gastric cancer
- Genialis merges and models data at the intersection of clinical and translational medicine- utilizing blending computational biology and AI-based method. Additionally- Genialis to present its work on predictive models for patient stratification at the Precision Medicine World Conference in CA
Click here to read full press release/ article | Ref: Businesswire | Image: Genialis
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com